Trial intelligence / Profile preview

Metformin for depression with abdominal obesity

ACTRN12613000856718Phase 4Recruiting

Sponsor
The Alfred Hospital
Start
Jun 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in major depressive disorder (MDD) comparing Metformin with Placebo (2 arms). Primary endpoint: Severity of depression. Started Jun 2014; status: recruiting.

02

Drugs

metformin
03

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on ACTRN12613000856718.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12613000856718.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call